ImpriMed
4 known investors
ImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions. The company serves veterinary oncology and drug development efforts in the animal health field.
Investors Β· 4
Frequently asked questions
- What does ImpriMed do?
- ImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions. The company serves veterinary oncology and drug development efforts in the animal health field.
- Who are ImpriMed's investors?
- ImpriMed's investors include Blue Bear Ventures, DFJ DragonFund, Draper Associates, Han River Partners.